Clinical Trial Detail

NCT ID NCT03844750
Title Pembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin + Oxaliplatin

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.